Who invested in NGI?
NGI's investors include Auriga Partners, Quest for Growth, Sanofi-Genzyme BioVentures and Beviguen.
France · Series A startup
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$12Mraised across 1 round since 2007, from 1 source
Reported by accessmylibrary.com
NGI's investors include Auriga Partners, Quest for Growth, Sanofi-Genzyme BioVentures and Beviguen.
NGI has raised $12M across 1 round since 2007.
NGI's most recent round was a Series A of $12M in Dec 2007.
Its most recent round, $12M in Dec 2007, is also its largest on record.
NGI's first round on record, in Dec 2007, was backed by Auriga Partners, Quest for Growth and Sanofi-Genzyme BioVentures and 1 others.
NGI's latest named round is a Series A, in Dec 2007.
NGI is based in France.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.